Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Theofanis Floros"'
Autor:
Georgios N. Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi, Anna Koumarianou, Christos Markopoulos, Konstantinos Papazisis, Vasileios Venizelos, Ioannis Xanthakis, Grigorios Xepapadakis, Eugeniu Banu, Dan Tudor Eniu, Serban Negru, Dana Lucia Stanculeanu, Andrei Ungureanu, Vahit Ozmen, Sualp Tansan, Mehmet Tekinel, Suayib Yalcin, George Nasioulas
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
Abstract Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause
Externí odkaz:
https://doaj.org/article/dc43f140d22c4f09805d95f871555460
Autor:
Theresa L. Whiteside, Stephan Lang, Edwin K. Jackson, Chang-Sook Hong, Marie-Nicole Theodoraki, Theofanis Floros, Sonja Ludwig
'Supp. Table 1 shows clinicopathological characteristics of patients. Supp. Fig. 1 shows Densitometry measurements. Supp. Fig. 2 shows No correlation between FasL expression & Annexin V binding.'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b5ddc1bf229bd38a6d92a7ba6eea7e
https://doi.org/10.1158/1078-0432.22462047
https://doi.org/10.1158/1078-0432.22462047
Autor:
GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN, GEORGE NASIOULAS
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to present data that demonstrate the different levels of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17928cee2350acf8044f319ac3d2bec4
https://europepmc.org/articles/PMC8717958/
https://europepmc.org/articles/PMC8717958/
Autor:
Ourania Katopodi, George Nasioulas, Stavroula Kampouri, Georgia Pepe, Rodoniki Iosifidou, Dan Tudor Eniu, Eirini Papadopoulou, Anna Koumarianou, Christos Markopoulos, Mehmet Tekinel, Serban Negru, Ioannis Xanthakis, V. Venizelos, Grigorios Xepapadakis, Sualp Tansan, Vahit Ozmen, Konstantinos Papazisis, Suayib Yalcin, Georgios N. Tsaousis, Nikolaos Diamantopoulos, E Banu, Theofanis Floros, Dana Lucia Stanculeanu, Konstantinos Agiannitopoulos, A Ungureanu, Angela Apessos
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
BMC Cancer
BMC Cancer
Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause of cancer
Autor:
Georgios Sirakoulis, Michail-Antisthenis Tsompanas, Nikolaos Dourvas, Karolos-Alexandros Tsakalos, Theofanis Floros
Publikováno v:
National Information Processing Institute
During the last years, a well studied biological substrate, namely Physarum polycephalum, has been proven efficient on finding appropriate and efficient solutions in hard to solve complex mathematical problems. The plasmodium of P. polycephalum is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f805cfeed9b5e622af9bd90141c0cb
Autor:
Chang-Sook Hong, Stephan Lang, Sonja Ludwig, Edwin K. Jackson, Marie-Nicole Theodoraki, Theresa L. Whiteside, Theofanis Floros
Publikováno v:
Clinical Cancer Research. 23:4843-4854
Purpose: Head and neck cancers (HNCs) often induce profound immunosuppression, which contributes to disease progression and interferes with immune-based therapies. Body fluids of patients with HNC are enriched in exosomes potentially engaged in negat
Autor:
Mark A. Socinski, Athanassios Argiris, Jill M. Siegfried, Theofanis Floros, Sanja Dacic, Imran Rafique, Jose Gomez-Garcia, Timothy F. Burns, Daniel P. Petro, Phu Tran, Laura P. Stabile, David M. Friedland, Ahmad A. Tarhini, Mariya Farooqui, Autumn Gaither-Davis, William E. Gooding, Liza C. Villaruz
Publikováno v:
Cancer. 123:2936-2944
BACKGROUND Activation of the mesenchymal-epidermal transition factor (MET) tyrosine kinase and its ligand, hepatocyte growth factor (HGF), is implicated in resistance to epidermal growth factor receptor (EGFR) inhibitors. In this phase 1/2 trial, ril
Autor:
Theofanis Floros, Ahmad A. Tarhini
Publikováno v:
Seminars in Oncology. 42:539-548
Efforts over nearly four decades have focused on ways to use cytokines to manipulate the host immune response towards cancer cell recognition and eradication. Significant advances were achieved with interleukin-2 (IL-2) and interferon-α (IFN-α), pr
Autor:
Vasiliki Metaxa-Mariatou, Elias Athanasiadis, Eugenia Bourkoula, Aikaterini Scapeti, Nikolaos Tsoulos, Stylianos Kakolyris, George Nasioulas, George Pentheroudakis, Chrisoula Efstathiadou, Anca Dinischiotu, Eirini Papadopoulou, Theofanis Floros, Vasileios Barbounis, Georgia Tounta, Georgios N. Tsaousis, P. Papakotoulas, Anna Koumarianou, Ioannis Boukovinas, P. Zarogoulidis
Publikováno v:
Oncology Reports
Non‑small cell lung cancer (NSCLC) is the most common type of lung cancer and a tumor with a broad spectrum of targeted therapies already available or in clinical trials. Thus, molecular characterization of the tumor using next generation sequencin
Autor:
Madeeha Ashraf, Uma N. M. Rao, William F. LaFramboise, Monica C. Panelli, Zahra Rahman, Hui-Min Lin, Cindy Sander, Priyanka Vallabhaneni, Theofanis Floros, John M. Kirkwood, Yan Lin, Ahmad A. Tarhini
Publikováno v:
Melanoma research. 27(5)
The purpose of this study was to learn whether molecular characterization through gene expression profiling of node-positive and node-negative sentinel lymph nodes (SLNs) in patients with clinical stage I and II melanoma may improve the understanding